BioPharma, Pharma At JPM, Top GSK Cancer Executive Talks Drug Targets and Oncology Strategy By Frank Vinluan
MedCity Influencers, Consumer / Employer Why Cancer Centers of Excellence May Not Be Right for Every Patient By Andrew Norden
BioPharma, Pharma In Key Study, Servier Drug Delays Brain Cancer in Patients With Few Treatment Options By Frank Vinluan
Consumer / Employer Carrum Health Secures $45M To Expand Cancer Care Offerings for Employers By Marissa Plescia
Consumer / Employer Rural Americans have difficulty accessing a promising cancer treatment By Debby Waldman, Kaiser Health News
BioPharma, Pharma FDA approval of AstraZeneca drug is first for a new group of breast cancer patients By Frank Vinluan
BioPharma, Pharma GSK immunotherapy shows promise as alternative to surgery in certain rectal cancers By Frank Vinluan
BioPharma, Pharma ASCO recap: Breast cancer breakthrough, Mirati’s moves, Arcellx ascends & more By Frank Vinluan
BioPharma, Pharma AstraZeneca, Daiichi Sankyo have high hopes for drug that goes low in breast cancer By Frank Vinluan
Devices & Diagnostics, Artificial Intelligence, Health Tech FDA clears wearable 3D ultrasound for breast imaging By Michael Schroeder
Devices & Diagnostics, Artificial Intelligence, Health Tech Paige launches software to help detect breast cancer that has spread to the lymph nodes By Michael Schroeder
Legal, Devices & Diagnostics, Payers CMS wants to repeal breakthrough device coverage rule, dashing med device industry hopes By Anuja Vaidya
